Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives

Archived

Office of the Assistant Secretary for Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

This notice solicits applications to demonstrate the feasibility and effectiveness of providing financial incentives to providers to improve the quality of life of children with sickle cell disease (SCD) through increased prescription rates of hydroxyurea. This initiative is not issued or funded by the Centers for Medicare and Medicaid Services (CMS).

Who can apply

  • Others

Contact

Grants.gov Contact Center<br/>Phone Number: 1-800-518-4726<br/><br/>Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays.<br/>support@grants.gov
support@grants.gov

Key dates & funding
  • PostedJul 28, 2020
  • ClosesAug 27, 2020
  • Award floor$750,000
  • Award ceiling$1,250,000
  • Program funding$2,500,000
  • Expected awards2
  • CFDA93.137
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro